The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Online fundraiser established for Local 821 officer’s family
- Ground broken on Brightline West — new rail jobs incoming!
- After FRA rule, Jared Cassity explains why we still need the Rail Safety Act
- ALERT for L.A.-area members — operator stabbing suspect at large
- SMART-TD wins SEPTA members’ security in their chosen craft
- Shining brightly in the midst of darkness
- Early-bird pricing for TD National Training Seminar ends April 30
- SMART-TD endorses U.S. Sen. Mike Braun (R-Indiana) as the next governor of the Hoosier State!
- FTA action on bus, transit safety plans praised by SMART-TD
- 27 transit members reinstated back to work in Montebello, California